Literature DB >> 20810736

Effective formation of the segregation-competent complex determines successful partitioning of the bovine papillomavirus genome during cell division.

Toomas Silla1, Andres Männik, Mart Ustav.   

Abstract

Effective segregation of the bovine papillomavirus type 1 (BPV1), Epstein-Barr virus (EBV), and Kaposi's sarcoma-associated human herpesvirus type 8 (KSHV) genomes into daughter cells is mediated by a single viral protein that tethers viral genomes to host mitotic chromosomes. The linker proteins that mediate BPV1, EBV, and KSHV segregation are E2, LANA1, and EBNA1, respectively. The N-terminal transactivation domain of BPV1 E2 is responsible for chromatin attachment and subsequent viral genome segregation. Because E2 transcriptional activation and chromatin attachment functions are not mutually exclusive, we aimed to determine the requirement of these activities during segregation by analyzing chimeric E2 proteins. This approach allowed us to separate the two activities. Our data showed that attachment of the segregation protein to chromatin is not sufficient for proper segregation. Rather, formation of a segregation-competent complex which carries multiple copies of the segregation protein is required. Complementation studies of E2 functional domains indicated that chromatin attachment and transactivation functions must act in concert to ensure proper plasmid segregation. These data indicate that there are specific interactions between linker molecules and transcription factors/complexes that greatly increase segregation-competent complex formation. We also showed, using hybrid E2 molecules, that restored segregation function does not involve interactions with Brd4.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810736      PMCID: PMC2953149          DOI: 10.1128/JVI.01366-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

1.  Interaction of the papillomavirus E2 protein with mitotic chromosomes.

Authors:  N Bastien; A A McBride
Journal:  Virology       Date:  2000-04-25       Impact factor: 3.616

2.  Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300.

Authors:  T K Kundu; V B Palhan; Z Wang; W An; P A Cole; R G Roeder
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

3.  Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes.

Authors:  Anita Krithivas; Masahiro Fujimuro; Magdalena Weidner; David B Young; S Diane Hayward
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16.

Authors:  William Alazawi; Mark Pett; Barbara Arch; Laurie Scott; Tom Freeman; Margaret A Stanley; Nicholas Coleman
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

5.  E1 initiator DNA binding specificity is unmasked by selective inhibition of non-specific DNA binding.

Authors:  Arne Stenlund
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

6.  Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes.

Authors:  T Piolot; M Tramier; M Coppey; J C Nicolas; V Marechal
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  The DNA segregation mechanism of Epstein-Barr virus nuclear antigen 1.

Authors:  H Wu; D F Ceccarelli; L Frappier
Journal:  EMBO Rep       Date:  2000-08       Impact factor: 8.807

8.  Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates.

Authors:  W L Kraus; E T Manning; J T Kadonaga
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

9.  The H1 and H2 regions of the activation domain of herpes simplex virion protein 16 stimulate transcription through distinct molecular mechanisms.

Authors:  Keiko Ikeda; Thomas Stuehler; Michael Meisterernst
Journal:  Genes Cells       Date:  2002-01       Impact factor: 1.891

10.  TATA-binding protein-free TAF-containing complex (TFTC) and p300 are both required for efficient transcriptional activation.

Authors:  Sara Hardy; Marjorie Brand; Gerhard Mittler; Jun Yanagisawa; Shigeaki Kato; Michael Meisterernst; Làszlò Tora
Journal:  J Biol Chem       Date:  2002-07-09       Impact factor: 5.157

View more
  6 in total

1.  Identification and analysis of papillomavirus E2 protein binding sites in the human genome.

Authors:  Liisi Võsa; Aleksander Sudakov; Maido Remm; Mart Ustav; Reet Kurg
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

2.  Evidence supporting a role for TopBP1 and Brd4 in the initiation but not continuation of human papillomavirus 16 E1/E2-mediated DNA replication.

Authors:  Elaine J Gauson; Mary M Donaldson; Edward S Dornan; Xu Wang; Molly Bristol; Jason M Bodily; Iain M Morgan
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

3.  Failure to interact with Brd4 alters the ability of HPV16 E2 to regulate host genome expression and cellular movement.

Authors:  Elaine J Gauson; Xu Wang; Edward S Dornan; Pawel Herzyk; Molly Bristol; Iain M Morgan
Journal:  Virus Res       Date:  2015-09-10       Impact factor: 3.303

4.  Interaction with TopBP1 Is Required for Human Papillomavirus 16 E2 Plasmid Segregation/Retention Function during Mitosis.

Authors:  Apurva T Prabhakar; Claire D James; Dipon Das; Christian T Fontan; Raymonde Otoa; Xu Wang; Molly L Bristol; Iain M Morgan
Journal:  J Virol       Date:  2022-07-26       Impact factor: 6.549

5.  Human Papillomavirus Type 18 cis-Elements Crucial for Segregation and Latency.

Authors:  Mart Ustav; Fernando Rodriguez Castaneda; Tormi Reinson; Andres Männik; Mart Ustav
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

Review 6.  Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle.

Authors:  Alison A McBride; Moon Kyoo Jang
Journal:  Viruses       Date:  2013-05-30       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.